Skip to main content
Premium Trial:

Request an Annual Quote

Heiri Gugger, Keith Davis, Doug Morton, Brett Farabaugh, Peter Johnson, Robert Goodman, Susan Harlander, Michael Summers, Linda Rubinstein, Kathy San Roman, Vance Wheelock, Jason Alter

Premium

Icoria this week announced several executive changes resulting from its realignment from an agricultural genomics company to a biomarker-discovery shop.

First, the company has created an Office of the President, which will be led by Heiri Gugger, current president and CEO. Members of the Office include: Keith Davis, currently Icoria's vice president of agricultural biotechnology, who will oversee Icoria's agricultural commitments during the transition; and Doug Morton, an Icoria director who is currently CEO of Southwest Michigan Innovation Center, a biotech incubator. According to Icoria, Morton "will play a leading role in helping Icoria build its healthcare business."

Additionally, Icoria said that Brett Farabaugh, former senior director of finance and chief accounting officer, has been named vice president of finance; and Peter Johnson, executive vice president and chief medical officer, is leaving the company for personal reasons and to pursue other interests.

Finally, three board members have advised Icoria that they will resign or not stand for re-election at the company's May 11 annual meeting: Robert Goodman, Susan Harlander, and Michael Summers.

Icoria last week sold its ag-genomics assets to Monsanto for $6.75 million, exiting the ag-genomics business and refashioning itself as a biomarker-discovery company. Icoria, formerly known as Paradigm Genetics, said it expects to reduce its headcount by 70 staffers by the end of the second quarter, bringing headcount to 120. It added that 60 of these employees are expected to join Monsanto. Additional lay-offs occurred at Icoria's Pittsburgh offices, the company said.


Solexa has appointed Linda Rubinstein as vice president, effective March 22. Rubinstein, 38, will assume the position of chief financial officer after Solexa files its 2004 annual report with the SEC. Kathy San Roman, who currently holds the position of acting chief financial officer, will continue as Solexa's vice president of human resources and administration.


Vance Wheelock has joined BioAnalyte to "consult on e-commerce solutions" and to advise the company on selling its proNets and pepNets licenses, which permit analytical instrument users to process datasets using the company's Trawler products on a per-dataset basis. Wheelock co-founded the Maine Linux User Group in 1995, and founded the Southern Maine Linux Users Group in 2000. Until last fall, Wheelock was the lead web developer for Blue Marble Geographics, a mapping software company.


TurboWorx has tapped Jason Alter as its new director of marketing. Alter joins TurboWorx from IBM, where he was most recently manager of program marketing for the Healthcare and Life Sciences business unit. Prior to that, he held a number of marketing roles at IBM Life Sciences.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.